← UNITEDHEALTH GROUP INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net earnings $7.1b
$10.8b +53.02%
$12.4b +14.40%
$14.2b +15.00%
$15.8b +10.75%
$17.7b +12.45%
$20.6b +16.39%
$23.1b +12.14%
$15.2b -34.14%
$12.8b -15.98%
—
Net Income (Loss) Attributable to Parent $7.0b
$10.6b +50.46%
$12.0b +13.53%
$13.8b +15.46%
$15.4b +11.30%
$17.3b +12.22%
$20.1b +16.40%
$22.4b +11.24%
$14.4b -35.64%
$12.1b -16.31%
—
Net Income (Loss) Attributable to Noncontrolling Interest $56.0m $265.0m $396.0m $400.0m $366.0m $447.0m $519.0m $763.0m $837.0m $751.0m —
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $7.1b $10.8b $12.4b $14.2b $15.8b $17.7b $20.6b $23.1b $15.2b $12.8b —
Amortization of Intangible Assets $882.0m $896.0m $898.0m $1.0b $1.1b $1.2b $1.3b $1.6b $1.7b $1.7b —
Capitalized Computer Software, Amortization $475.0m $550.0m $606.0m $721.0m $814.0m $923.0m $1.0b $1.2b $1.4b $1.7b —
Depreciation $698.0m $799.0m $924.0m $995.0m $997.0m $996.0m $1.1b $1.1b $1.0b $1.0b $4.3b
Depreciation and amortization $2.1b $2.2b $2.4b $2.7b $2.9b $3.1b $3.4b $4.0b $4.1b $4.4b $4.3b
Deferred Income Tax Expense (Benefit) $81.0m ($965.0m) $42.0m $230.0m ($8.0m) $130.0m ($673.0m) ($245.0m) ($296.0m) ($1.8b) ($1.3b)
Share-based Payment Arrangement, Noncash Expense $485.0m $597.0m $638.0m $697.0m $679.0m $800.0m $925.0m $1.1b $1.0b $971.0m $944.0m
Share-based compensation $485.0m $597.0m $638.0m $697.0m $679.0m $800.0m $925.0m $1.1b $1.0b $971.0m $944.0m
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 —
Impairment of Intangible Assets (Excluding Goodwill) $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 —
Changes in operating assets and liabilities:
Accounts receivable ($1.4b) ($1.1b) ($1.4b) $162.0m ($688.0m) ($1.0b) ($2.5b) ($3.1b) ($1.4b) ($764.0m) $154.0m
Increase (Decrease) in Accounts Receivable $1.4b $1.1b $1.4b ($162.0m) $688.0m $1.0b $2.5b $3.1b $1.4b $764.0m $154.0m
Accounts payable and other liabilities $1.5b $930.0m $526.0m $733.0m $5.3b $1.2b $2.0b $3.5b $2.5b $1.7b $3.3b
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims $117.0b $130.0b $145.4b $156.4b $159.4b $186.9b $210.8b $241.9b $264.2b $314.0b —
Unearned revenues ($202.0m) $157.0m $38.0m $130.0m $278.0m ($310.0m) $126.0m $203.0m ($197.0m) $163.0m —
Increase (Decrease) in Other Operating Assets $1.6b $630.0m $750.0m $1.6b $2.2b $1.0b $1.4b $2.4b $4.1b $4.6b —
Other assets ($1.6b) ($630.0m) ($750.0m) ($1.6b) ($2.2b) ($1.0b) ($1.4b) ($2.4b) ($4.1b) ($4.6b) —
Net Cash Provided by (Used in) Operating Activities $9.8b
$13.6b +38.81%
$15.7b +15.57%
$18.5b +17.50%
$22.2b +20.10%
$22.3b +0.76%
$26.2b +17.29%
$29.1b +10.92%
$24.2b -16.73%
$19.7b -18.62%
$23.2b +17.55%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $1.7b $2.0b $2.1b $2.1b $2.1b $2.5b $2.8b $3.4b $3.5b $3.6b ($3.5b)
Maturities of investments $4.3b $5.6b $6.3b $7.1b $7.3b $8.3b $6.1b $9.2b $9.3b $8.4b —
Payments to Acquire Investments $17.5b $14.6b $14.0b $18.1b $16.6b $17.1b $18.8b $18.3b $27.3b $17.4b ($19.8b)
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $4.3b $5.6b $6.3b $7.1b $7.3b $8.3b $6.1b $9.2b $9.3b $8.4b —
Purchases of investments ($17.5b) ($14.6b) ($14.0b) ($18.1b) ($16.6b) ($17.1b) ($18.8b) ($18.3b) ($27.3b) ($17.4b) —
Sales of investments $7.3b $4.6b $3.6b $8.5b $6.5b $7.0b $5.9b $7.3b $18.5b $9.3b —
Cash paid for acquisitions and other transactions, net of cash assumed ($1.8b) ($2.1b) ($6.0b) ($8.3b) ($7.1b) ($4.8b) ($21.5b) ($10.1b) ($13.4b) ($4.5b) —
Payments to Acquire Businesses, Net of Cash Acquired $1.8b $2.1b $6.0b $8.3b $7.1b $4.8b $21.5b $10.1b $13.4b $4.5b ($3.8b)
Payments for (Proceeds from) Other Investing Activities ($37.0m) $126.0m $226.0m ($219.0m) $506.0m $1.3b $793.0m $960.0m $1.7b $341.0m —
Net Cash Provided by (Used in) Investing Activities ($9.4b) ($8.6b) ($12.4b) ($12.7b) ($12.5b) ($10.4b) ($28.5b) ($15.6b) ($20.5b) ($8.7b) ($11.1b)
Cash flows from financing activities:
Proceeds from (repayments of) short-term borrowings, net ($382.0m) ($3.5b) ($201.0m) $300.0m $872.0m ($1.3b) $732.0m $11.0m ($151.0m) $807.0m —
Proceeds from Issuance of Long-term Debt $4.0b $5.3b $6.9b $5.4b $4.9b $6.9b $14.8b $6.4b $17.8b $3.0b $14.9b
Repayments of Long-term Debt $2.6b $4.4b $2.6b $1.8b $3.1b $3.1b $3.0b $2.1b $3.0b $3.0b ($4.5b)
Payments for Repurchase of Common Stock $1.3b $1.5b $4.5b $5.5b $4.2b $5.0b $7.0b $8.0b $9.0b $5.5b —
Payments of Ordinary Dividends, Common Stock $2.3b $2.8b $3.3b $3.9b $4.6b $5.3b $6.0b $6.8b $7.5b $7.9b ($8.0b)
Proceeds from Issuance of Common Stock $429.0m $688.0m $838.0m $1.0b $1.4b $1.4b $1.3b $1.4b $1.8b $827.0m $698.0m
Proceeds from common stock issuances $429.0m $688.0m $838.0m $1.0b $1.4b $1.4b $1.3b $1.4b $1.8b $827.0m —
Cash dividends paid ($2k) ($3k) ($3k) ($4k) ($5k) ($5k) ($6k) ($7k) ($8k) ($8k) ($8.0b)
Proceeds from (Payments for) Other Financing Activities ($324.0m) ($413.0m) ($1.4b) ($1.2b) ($459.0m) ($295.0m) ($1.9b) ($1.1b) ($1.6b) $63.0m —
Net Cash Provided by (Used in) Financing Activities ($1.0b)
($3.4b) -240.36%
($4.4b) -26.85%
($5.6b) -28.87%
($3.6b) +36.18%
($7.5b) -107.66%
$4.2b +156.69%
($11.5b) -372.81%
($3.5b) +69.54%
($11.6b) -231.55%
($14.7b) -26.55%
(Decrease) increase in cash and cash equivalents, including cash within businesses held for sale — — — — — — $2.0b $2.1b $104.0m ($592.0m) —
Net (decrease) increase in cash and cash equivalents — — ($1.1b) $119.0m $5.9b $4.5b $2.0b $2.1b ($115.0m) ($947.0m) —
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $78.0m ($5.0m) ($78.0m) ($20.0m) $5.9b $4.5b $2.0b $2.1b ($115.0m) ($947.0m) $28.1b
Cash and cash equivalents, beginning of period $10.9b $10.4b $12.0b $10.9b $11.0b $16.9b $23.4b $25.4b $25.3b $24.4b —
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — — — — $23.4b $25.4b $25.3b $24.4b $28.1b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78.0m ($5.0m) ($78.0m) ($20.0m) ($116.0m) ($62.0m) $34.0m $97.0m ($61.0m) $40.0m $18.0m
Effect of exchange rate changes on cash and cash equivalents $78.0m ($5.0m) ($78.0m) ($20.0m) ($116.0m) ($62.0m) $34.0m $97.0m ($61.0m) $40.0m $18.0m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Additional Financial Items
Cash flows used for financing activities ($1.0b) ($3.4b) ($4.4b) ($5.6b) ($3.6b) ($7.5b) $4.2b ($11.5b) ($3.5b) ($11.6b) —
Cash flows used for investing activities ($9.4b) ($8.6b) ($12.4b) ($12.7b) ($12.5b) ($10.4b) ($28.5b) ($15.6b) ($20.5b) ($8.7b) —
Cash received from dispositions, net — — — — $221.0m $15.0m $3.4b $685.0m $2.0b $561.0m —
Common share repurchases ($1.3b) ($1.5b) ($4.5b) ($5.5b) ($4.2b) ($5.0b) ($7.0b) ($8.0b) ($9.0b) ($5.5b) —
Customer funds administered $1.7b $3.2b ($131.0m) $13.0m $1.7b $622.0m $5.5b ($521.0m) ($1.6b) $366.0m —
Deconsolidation, Gain (Loss), Amount — — — — — — — — — $1.7b —
Gain (Loss) on Disposition of Business — — — — — — — — $3.3b $910.0m —
Goodwill $47.6b $54.6b $58.9b $65.7b $71.3b $75.8b $93.4b $103.7b $106.7b $110.5b —
Income Tax Expense (Benefit) $4.8b $3.2b $3.6b $3.7b $5.0b $4.6b $5.7b $6.0b $4.8b $1.9b —
Income Taxes Paid, Net $4.7b $4.0b $3.3b $3.5b $4.9b $4.0b $5.2b $6.1b $4.6b $3.7b —
Interest Paid, Excluding Capitalized Interest, Operating Activities $1.1b $1.1b $1.4b $1.6b $1.7b $1.7b $1.9b $3.0b $3.6b $4.0b —
Less: net increase in cash within businesses held for sale — — — — — — $0 $0 ($219.0m) ($355.0m) —
Loans to care providers - cyberattack — — — — — — $0 $0 ($9.0b) $0 —
Loss on sale of subsidiary and subsidiaries held for sale — — — — — — $0 $0 $8.3b $265.0m —
Medical costs payable $1.8b $1.3b $1.8b $1.2b $152.0m $2.7b $4.1b $3.5b $2.5b $5.8b —
Net gains on dispositions and other strategic transactions — — — — — — ($588.0m) ($489.0m) ($3.3b) ($910.0m) —
Originations and purchases of loans — — — — — — — ($1.7b) ($2.5b) ($4.8b) —
Other, net ($324.0m) ($413.0m) ($1.4b) ($1.2b) ($459.0m) ($295.0m) ($1.9b) ($1.1b) ($1.6b) $63.0m —
Purchases of redeemable noncontrolling interests ($257.0m) — — ($618.0m) $0 ($1.3b) ($176.0m) ($730.0m) ($280.0m) ($165.0m) —
Repayments and maturities of loans — — — — — — — $613.0m $908.0m $2.0b —
Repayments of care provider loans - cyberattack — — — — — — $0 $0 $4.5b $1.7b —
Restructuring Costs — — — — — — — — — $2.5b —
Supplemental disclosure of cash flow information:

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.